Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality

Y Que, C Hu, K Wan, P Hu, R Wang, J Luo… - International reviews …, 2022 - Taylor & Francis
Abstract The coronavirus disease 2019 (COVID-19) triggered by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) erupted in Hubei Province of China in December …

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

N Moradian, M Gouravani, MA Salehi, A Heidari… - European cytokine …, 2020 - Springer
Abstract Coronavirus disease (COVID-19) reached pandemic proportions at the beginning
of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory …

The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?

D Darif, I Hammi, A Kihel, IEI Saik, F Guessous… - Microbial …, 2021 - Elsevier
The outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) infection, has emerged in China in December 2019 …

The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease

R Pasrija, M Naime - International Immunopharmacology, 2021 - Elsevier
COVID-19 caused by the SARS-CoV-2 virus, accompanies an unprecedented spike in
cytokines levels termed cytokines release syndrome (CRS), in critically ill patients. Clinicians …

Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity

A Picchianti Diamanti, MM Rosado, C Pioli… - International journal of …, 2020 - mdpi.com
On 7 January 2020, researchers isolated and sequenced in China from patients with severe
pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide …

Definition and risks of cytokine release syndrome in 11 critically ill COVID-19 patients with pneumonia: analysis of disease characteristics

W Wang, X Liu, S Wu, S Chen, Y Li… - The Journal of …, 2020 - academic.oup.com
Abstract Corona virus disease 2019 (COVID-19) patients with severe immune abnormalities
are at risk of cytokine release syndrome (CRS). The definition, prevention, and treatment of …

Emerging evidence on multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection: a systematic review with meta-analysis

M Sood, S Sharma, I Sood, K Sharma… - SN comprehensive clinical …, 2021 - Springer
With the increased spread of severe acute respiratory syndrome coronavirus 2 infection,
more patients with multisystem inflammatory syndrome in children (MIS-C) are being …

Multisystem inflammatory syndrome in children related to SARS-CoV-2

S Esposito, N Principi - Pediatric Drugs, 2021 - Springer
Although data on the incidence and severity of new coronavirus disease 2019 (COVID-19)
due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection showed …

COVID-19 pandemic and children: a review

V Rathore, A Galhotra, R Pal… - The Journal of Pediatric …, 2020 - meridian.allenpress.com
The severe respiratory disease COVID-19 (coronavirus disease 2019) was first reported in
late December 2019 in Wuhan City, China. Soon thereafter, the World Health Organization …

[HTML][HTML] A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C)

F Haslak, M Yıldız, A Adrovic, S Şahin… - Turkish Archives of …, 2021 - ncbi.nlm.nih.gov
Humanity has recently gained a novel foe named coronavirus disease 2019. Although data
so far mostly suggest that children are more likely to have a favorable disease course, new …